These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 2930150)
1. [Anti-arrhythmia efficacy of propafenone per os in the prevention of paroxysmal supraventricular arrhythmia resistant to class Ia agents]. Boutaud P; Guillem JP; Maarek-Charbit M; Amiel A; Ciber M; Herpin D; Demange J Ann Cardiol Angeiol (Paris); 1989 Jan; 38(1):37-42. PubMed ID: 2930150 [TBL] [Abstract][Full Text] [Related]
2. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group. Circulation; 1995 Nov; 92(9):2550-7. PubMed ID: 7586356 [TBL] [Abstract][Full Text] [Related]
3. [The efficacy of propafenon in the case of supraventricular atrioventricular tachycardia]. Chachua T; Abuladze G; Nebieridze M Georgian Med News; 2010 Jun; (183):18-21. PubMed ID: 20622270 [TBL] [Abstract][Full Text] [Related]
4. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases]. Coumel P; Leclercq JF; Assayag P; Maisonblanche P; Cauchemez B Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1370-82. PubMed ID: 6439161 [TBL] [Abstract][Full Text] [Related]
5. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study]. Lardoux H; Maison Blanche P; Marchand X; Canler A; Rouesnel P; Bleinc D; Péraudeau P; Scheck F Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741 [TBL] [Abstract][Full Text] [Related]
6. [Supraventricular tachycardia with wide QRS complexes during Vaughan-Williams class I anti-arrhythmic treatment. Diagnostic and therapeutic implications]. Aouate P; Frank R; Fontaine G; Tonet J; Tageddine R; Benassar A; Turlure A; Jacquemin M; Laborde JP Arch Mal Coeur Vaiss; 1995 Dec; 88(12):1869-74. PubMed ID: 8729368 [TBL] [Abstract][Full Text] [Related]
7. [Intravenous and oral propafenone in the treatment and prevention of paroxysmal atrial fibrillation]. Cointe R; Metge M; Bru P; Vrancea F; Gerard R; Paganelli F; Lévy S Ann Cardiol Angeiol (Paris); 1993 Apr; 42(4):223-7. PubMed ID: 8517602 [TBL] [Abstract][Full Text] [Related]
8. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter. Chiladakis JA; Kalogeropoulos A; Patsouras N; Manolis AS J Am Coll Cardiol; 2004 Aug; 44(4):859-63. PubMed ID: 15312872 [TBL] [Abstract][Full Text] [Related]
9. [Use of propafenone in emergency therapy]. Liguori A; Pellegrino G; Di Ieso N; Piatto A; Ruggiero P; Scarnera P; Guardascione A Clin Ter; 1989 Dec; 131(5):307-14. PubMed ID: 2532584 [TBL] [Abstract][Full Text] [Related]
10. [The treatment of arrhythmias in infants and children using propafenone]. Dressler F; Grävinghoff L; Grütte E; Jüngst BK; Liersch R; Nomayo H; Puls I; Rautenburg HW; Schmaltz A; Schumacher G Monatsschr Kinderheilkd; 1985 Mar; 133(3):154-7. PubMed ID: 4010670 [TBL] [Abstract][Full Text] [Related]
11. [Efficacy of intravenous Acehytisine Hydrochloride versus propafenone on terminating paroxysmal supraventricular tachycardia: a double-blinded, randomized multi-center study]. Gao X; Zhu J; Yang YM; Li JD; Yang ZM; Liu JH; Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Feb; 35(2):151-4. PubMed ID: 17445412 [TBL] [Abstract][Full Text] [Related]
12. Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy. Pritchett EL; McCarthy EA; Wilkinson WE Ann Intern Med; 1991 Apr; 114(7):539-44. PubMed ID: 2001087 [TBL] [Abstract][Full Text] [Related]
13. Paroxysmal supraventricular tachycardia: experience with propafenone. Santinelli V; De Paola M; Turco P; Smimmo D; Chiariello M Angiology; 1989 Jun; 40(6):563-8. PubMed ID: 2719341 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the efficacy of propafenone versus disopyramide for complex premature ventricular contractions. Evaluation with long-term monitoring. Naccarella F; Palmieri M; del Corso P; Lombardi G; Bracchetti D Arzneimittelforschung; 1982; 32(5):547-50. PubMed ID: 7201833 [TBL] [Abstract][Full Text] [Related]
16. [Anti-arrhythmia efficacy of propafenone in children. Apropos of 30 cases]. Lucet V; Do Ngoc D; Fidelle J; Sidi D; Batisse A; Loth P; Vrancea F; Villain E; Coumel P Arch Mal Coeur Vaiss; 1987 Aug; 80(9):1385-93. PubMed ID: 3122689 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of dofetilide in the prevention of symptomatic episodes of paroxysmal supraventricular tachycardia: a 6-month double-blind comparison with propafenone and placebo. Tendera M; Wnuk-Wojnar AM; Kulakowski P; Malolepszy J; Kozlowski JW; Krzeminska-Pakula M; Szechinski J; Droszcz W; Kawecka-Jaszcz K; Swiatecka G; Ruzyllo W; Graff O Am Heart J; 2001 Jul; 142(1):93-8. PubMed ID: 11431663 [TBL] [Abstract][Full Text] [Related]
18. [Propafenone efficacy in preventing supraventricular tachycardia in childhood]. Bodegas A; Cabrera A; Sarrionaindía MJ; Idígoras G; Rumoroso JR; Pérez García P; Pastor E; Galdeano JM; Sota J; Barrenetxea JI Rev Esp Cardiol; 1994 Feb; 47(2):86-91. PubMed ID: 8165353 [TBL] [Abstract][Full Text] [Related]
19. [Oral propafenone in resistant auricular arrhythmia]. Bounhoure JP; Sabot G; Cassagneau B; Calazel J; Dechandol AM Ann Cardiol Angeiol (Paris); 1985; 34(7):485-8. PubMed ID: 4062207 [TBL] [Abstract][Full Text] [Related]
20. [Comparison of efficacy, safety and cost-effectiveness of intravenous versus oral propafenone in paroxysmal atrial fibrillation]. Zadura M; Grossmann G; Modrzewska A; Klecha T; Klepacka H; Rumiński W Pol Merkur Lekarski; 2001 Aug; 11(62):137-9. PubMed ID: 11757212 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]